Greenwich LifeSciences(GLSI) - 2021 Q4 - Annual Report

Washington, D.C. 20549 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION Form 10-K (Mark One) 3992 Bluebonnet Dr., Building 14, Stafford, Texas 77477 77477 Delaware 20-5473709 Commission File Number: 001-39555 (State or other jurisdiction of incorporation o ...